Last reviewed · How we verify
NCT07056686
Early Detection of Breast Cancer Among Syrian Women
trial testing Mammogram in Breast Cancer Detection in 1,000 participants. Enrolling by invitation.
31 May 2025
Quick facts
| Lead sponsor | Al-Hawash Private University |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 17 May 2025 |
| Primary completion | 31 May 2025 |
| Estimated completion | 30 July 2025 |
| Sites | 1 location across Syria |
Drugs / interventions tested
- Mammogram
Conditions studied
- Breast Cancer Detection — all drugs for Breast Cancer Detection →
Sponsor
Al-Hawash Private University
Who can join
Adults 18 to 65, female only, with Breast Cancer Detection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to evaluate breast cancer awareness, screening practices, and barriers to early detection among women in the middle region of Syria. The main questions it aims to answer are: 1. What is the level of awareness among women in this region regarding breast cancer symptoms and risk factors. 2. How do women practice breast self-examination and professional screenings. 3. What barriers prevent women from seeking early detection and treatment? Participants will complete a survey assessing their knowledge, behaviors, and challenges related to breast cancer screening. The findings will inform public health interventions to improve awareness and early detection practices.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07056686
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Mammogram
Trials testing the same drug.
- NCT07434128 — Mammogram Pretreatment With Ulipristal Acetate · Phase 2 · not yet recruiting
- NCT07277738 — Precision Supplemental Imaging in Women With Dense Breasts · NA · not yet recruiting
- NCT06671912 — Testing Low Dose Tamoxifen for Invasive Breast Cancer, the (LoTam) Trial · Phase 3 · suspended
- NCT05989828 — A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple N · Phase 1 · suspended
- NCT05919108 — Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers · Phase 2 · recruiting
Other recruiting trials for Breast Cancer Detection
Currently open trials in the same condition.
- NCT07331506 — Validation of the Oncoliq Test for the Early Detection of Breast Cancer. · recruiting
- NCT07214883 — UCF MammoChat: Image Repository · recruiting
- NCT07080515 — Developing Screening Clinical Breast Examination Implementation Strategies in Nigeria · recruiting
Other Al-Hawash Private University trials
Trials by the same sponsor.
- NCT07075666 — Early Detection of Prostate Cancer of Syrian Men · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07056686 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Al-Hawash Private University
- Last refreshed: 18 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07056686.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing